93Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Russia
Neuroscience Intelligence
Russia neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #32 of 50 · Data maturity A · Research score 33.3 · Data confidence 100.0 / 100 · Snapshot 2026-10-12 03:36 UTC.
9Recruiting trials
14Publications
76Institutions
Executive interpretation
Russia ranks #32 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Hoffmann-La Roche111 recruiting
Merck Sharp & Dohme LLC92 recruiting
Pfizer51 recruiting
Eli Lilly and Company50 recruiting
Sumitomo Pharma America, Inc.50 recruiting
GlaxoSmithKline40 recruiting
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.30 recruiting
Boehringer Ingelheim30 recruiting
Novo Nordisk A/S30 recruiting
AbbVie20 recruiting
Disease activity
Parkinsons14trials
Epilepsy11trials
Alzheimers11trials
Depression8trials
Stroke7trials
Neuromuscular4trials
Schizophrenia4trials
Bipolar Disorder4trials
Multiple Sclerosis4trials
Other Neurology3trials
Research institutions
National Medical Research Center of Surgery named after A. VishnevskyOpenAlexlinked institution
Engelhardt Institute of Molecular BiologyOpenAlexlinked institution
Vavilov Institute of General GeneticsOpenAlexlinked institution
Federal Medical Research Centre for Psychiatry and NarcologyOpenAlexlinked institution
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian FederationOpenAlexlinked institution
Ural Federal UniversityOpenAlexlinked institution
Institute of Developmental PhysiologyOpenAlexlinked institution
Peoples' Friendship University of RussiaOpenAlexlinked institution
Russian Society of CardiologyOpenAlexlinked institution
Association of Rheumatologists of RussiaOpenAlexlinked institution
Clinical evidence trail
NCT07390240The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia in RussiaRECRUITING
NCT04752774A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.RECRUITING
NCT04736706A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)ACTIVE_NOT_RECRUITING
NCT04544436A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)ACTIVE_NOT_RECRUITING
NCT04281485Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular DystrophyACTIVE_NOT_RECRUITING
NCT03887455A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's DiseaseACTIVE_NOT_RECRUITING
NCT03765918Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)ACTIVE_NOT_RECRUITING
NCT07155499A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V 1] and an Apple Allergen [MAL D 1]) in Patients With Birch Pollen Allergic Rhinitis.COMPLETED
NCT06863948Integrative Group Psychotherapy (Terebenin's Method) in Adults With Subclinical and Mild/Moderate Anxiety and DepressionCOMPLETED
Research evidence trail
PUBMEDPallidal physiology and predictors of successful deep brain stimulation in jerky dystonia, dystonia with tremor, and their combination.2026-08-01
OPENALEXImmune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives2022-04-25
OPENALEXSafety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia2021-02-01
OPENALEX2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension2018-11-01
OPENALEXTLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis2017-10-04
OPENALEXPost-stroke Rehabilitation Training with a Motor-Imagery-Based Brain-Computer Interface (BCI)-Controlled Hand Exoskeleton: A Randomized Controlled Multicenter Trial2017-07-20
OPENALEXPossible Mechanisms Underlying the Therapeutic Effects of Transcranial Magnetic Stimulation2015-06-16
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.